Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder
Authors:
Open Access
- 6 July 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 79 (8) , 760-769
Abstract
Autism spectrum disorder (ASD) is a common lifelong neurodevelopmental condition with an increasing global prevalence.1,2 The core symptoms of ASD are defined as difficulties in social communication/interaction and restrictive/repetitive behaviors.2 ASD is etiologically, biologically, and clinically heterogeneous; the genetic and environmental factors involved are still poorly understood.3 Current US Food and Drug Administration–approved medications do not target the core symptoms of ASD.4 There is an unmet need for approved pharmacologic therapies targeting the suspected underlying biologic pathways associated with the core symptoms of ASD.5Keywords
This publication has 31 references indexed in Scilit:
- Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping ApproachJournal of Medicinal Chemistry, 2015
- Baseline Factors Predicting Placebo Response to Treatment in Children and Adolescents With Autism Spectrum DisordersJAMA Pediatrics, 2013
- Measurement Tools and Target Symptoms/Skills Used to Assess Treatment Response for Individuals with Autism Spectrum DisorderJournal of Autism and Developmental Disorders, 2013
- Neuromodulation by Oxytocin and VasopressinNeuron, 2012
- Gestational Valproate Alters BOLD Activation in Response to Complex Social and Primary Sensory StimuliPLOS ONE, 2012
- P-640 - The power of expectation biasEuropean Psychiatry, 2012
- The association between Internet addiction and psychiatric disorder: A review of the literatureEuropean Psychiatry, 2012
- Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autismMolecular Autism, 2011
- Placebo Response in Randomized Controlled Trials of Antidepressants for Pediatric Major Depressive DisorderAmerican Journal of Psychiatry, 2009
- Interventions to Improve Communication in AutismChild and Adolescent Psychiatric Clinics of North America, 2008